Propranolol (Inderal - ICI) is now being promoted for the treatment of hypertension. It is claimed to be ‘at least as effective in reducing pressure as guanethidine, bethanidine and methyldopa’, while causing no postural hypotension or other unwanted effects of adrenergic blockade. However, its value for this purpose remains disputed.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.